Skip to main content
Commentary

National drug shortages worsen during COVID-19 crisis: proposal for a comprehensive model to monitor and address critical drug shortages.

Piatek OI, Ning JC, Touchette DR. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages. Am J Health Syst Pharm. 2020;7(21):1778–1785. Epub 2020/07/28. doi: 10.1093/ajhp/zxaa228.

Save
Print
November 4, 2020
Piatek OI, Ning JC-min, Touchette DR. Am J Health Syst Pharm. 2020;7(21):1778-1785.

Drug shortages are an ongoing threat to safe patient care. This commentary discusses the impact of COVID-19 on medication supply and demand, and the resulting drug shortages. The authors provide several recommendations for reducing future drug shortages in times of crises, including increasing stockpiles and creating a critical drug list with potential substitutes.

Save
Print
Cite
Citation

Piatek OI, Ning JC, Touchette DR. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages. Am J Health Syst Pharm. 2020;7(21):1778–1785. Epub 2020/07/28. doi: 10.1093/ajhp/zxaa228.